Forum Droghe is an association both of individuals and various organizations involved in the reform of drug policies, harm reduction in particular. Forum Droghe also promotes research about the evaluation of the impact of drug legislation on the prison and justice systems.
Our membership has been growing organically since IDPC was set up in 2006. Members can be NGOs, academic institutions, think tanks or professional networks, but they must have a national or international outlook, and a credible track record in the drug policy field.
There are no membership fees, but all members need to be committed to supporting the IDPC vision and mission, strategic directions, policy principles and work plan.
IDPC has two types of membership:
IDPC Partner Members
Partner Members are organisations that play a more active role in IDPC’s day-to-day work. These members have the skills, capacity and contacts to engage governments and international organisations on drug policy reform. This level of membership includes clear expectations in terms of involvement in consultations, efficient communication and contribution to the advocacy work. As a result, the selection of Partner Members will be based on the level of engagement of the organisation in IDPC’s work, geographical representation (with no more than one Partner Member per country in most cases), and thematic relevance.
IDPC Network Members
Network Members are organisations that are mostly involved in IDPC’s communications work at a less intensive level. These members receive all IDPC communications, and are involved in exchange of ideas and information, and joint planned activities. These members will be able to use the IDPC alerts and website to promote their work, and will help share IDPC’s news, publications and products with their own contacts. IDPC will usually welcome organisations as Network Members in the first instance, rather than as Partner Members.
The Luca Coscioni Association defends civil liberties, the right to self-determination and the freedom of research. In terms of drug policy, it believes in measures aiming at minimising harm, rather than a criminalization approach that always ends up working against marginalised groups